ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
AbbVie Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$282.68−2.74 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $500.63B
- P/E (TTM)
- 79.9
- Dividend yield
- 2.35%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
75.6%
1.34B of 1.77B shares
Institutional holders
4,210
286 new, 111 sold out
Net institutional buying
43M
In Q2 2026
Insider trades, 12 months
0 buys · 6 sales
Net sold $18.92M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 143,180,060 | 8.10% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 132,924,058 | 7.51% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ABBV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 149,488,412 | 8.46% | $37.62B | −1,209,713 | 0.56% |
| Vanguard Capital Management LLC | 115,396,098 | 6.53% | $29.04B | +515,774 | 0.62% |
| State Street Corp | 82,596,748 | 4.67% | $20.78B | +1,379,232 | 0.62% |
| Vanguard Portfolio Management LLC | 48,477,996 | 2.74% | $12.20B | −1,045,082 | 0.55% |
| JPMorgan Chase & Co | 47,862,796 | 2.71% | $12.17B | −8,878,895 | 0.67% |
| Geode Capital Management, LLC | 46,998,433 | 2.66% | $11.81B | +260,852 | 0.63% |
| Morgan Stanley | 38,901,001 | 2.20% | $9.79B | +884,227 | 0.52% |
| Capital Research Global Investors | 30,101,551 | 1.70% | $7.57B | −1,153,235 | 1.06% |
| Norges Bank | 25,554,538 | 1.45% | $6.43B | New | 0.64% |
| Bank Of America Corp /De/ | 21,237,764 | 1.20% | $5.34B | −2,699,179 | 0.34% |
| FMR LLC | 20,773,786 | 1.18% | $5.23B | −988,917 | 0.23% |
| Northern Trust Corp | 20,558,447 | 1.16% | $5.17B | −652,935 | 0.60% |
| Franklin Resources Inc | 19,925,232 | 1.13% | $5.01B | +5,373,163 | 1.09% |
| Capital World Investors | 19,178,966 | 1.09% | $4.83B | +3,337,599 | 0.57% |
| Goldman Sachs Group Inc | 16,291,630 | 0.92% | $4.10B | +1,146,351 | 0.36% |
| Capital International Investors | 15,638,631 | 0.88% | $3.94B | +1,219,638 | 0.81% |
| Price T Rowe Associates Inc /Md/ | 14,749,069 | 0.83% | $3.71M | +1,745,080 | 0.37% |
| UBS Asset Management Americas Inc | 14,267,697 | 0.81% | $3.59B | +106,091 | 0.65% |
| Charles Schwab Investment Management Inc | 12,914,230 | 0.73% | $3.25B | −53,168 | 0.43% |
| Bank of New York Mellon Corp | 12,853,368 | 0.73% | $3.23B | −424,793 | 0.53% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 4,210 | 1.34B | 75.6% | 286 / 1921 | 1534 / 111 | 99M | 55M |
| Q1 2026 | 4,104 | 1.30B | 73.7% | 192 / 1731 | 1717 / 182 | 258M | 97M |
| Q4 2025 | 4,159 | 1.33B | 75.0% | 458 / 1602 | 1647 / 125 | 98M | 98M |
| Q3 2025 | 3,915 | 1.33B | 75.2% | 295 / 1662 | 1474 / 101 | 102M | 72M |
| Q2 2025 | 3,787 | 1.30B | 73.7% | 182 / 1709 | 1470 / 167 | 80M | 65M |
| Q1 2025 | 3,826 | 1.29B | 73.0% | 266 / 1491 | 1630 / 125 | 69M | 55M |
| Q4 2024 | 3,749 | 1.29B | 72.8% | 440 / 1501 | 1415 / 131 | 85M | 113M |
| Q3 2024 | 3,506 | 1.32B | 74.9% | 244 / 1424 | 1398 / 71 | 177M | 39M |
| Q2 2024 | 3,371 | 1.32B | 74.8% | 154 / 1474 | 1316 / 125 | 57M | 111M |
| Q1 2024 | 3,385 | 1.38B | 78.1% | 222 / 1337 | 1493 / 116 | 98M | 45M |
| Q4 2023 | 3,327 | 1.33B | 75.3% | 367 / 1177 | 1423 / 98 | 137M | 35M |
| Q3 2023 | 3,114 | 1.23B | 69.8% | 176 / 1278 | 1284 / 106 | 42M | 36M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ABBV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 56,090,167 | 3.17% | $14.11B | 0.61% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 45,784,614 | 2.59% | $11.52B | 0.69% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 24,302,850 | 1.38% | $6.12B | 0.69% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 22,617,268 | 1.28% | $4.92B | 0.59% | May 31, 2026 |
| Vanguard Value Index Fund | 16,815,764 | 0.95% | $4.23B | 1.66% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 12,481,854 | 0.71% | $3.14B | 7.74% | Jun 30, 2026 |
| American Mutual Fund | 11,145,520 | 0.63% | $2.80B | 2.37% | Jul 31, 2026 |
| Capital Income Builder | 10,055,634 | 0.57% | $2.52B | 1.93% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 9,996,424 | 0.57% | $2.51B | 1.92% | Jul 31, 2026 |
| Washington Mutual Investors Fund | 9,627,943 | 0.54% | $2.42B | 1.11% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 9,591,323 | 0.54% | $2.41B | 0.69% | Jun 30, 2026 |
| Income Fund of America | 8,590,236 | 0.49% | $2.16B | 1.45% | Jul 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 7,128,692 | 0.40% | $1.79B | 1.80% | Jul 31, 2026 |
| Investment Co of America | 6,525,474 | 0.37% | $1.64B | 0.89% | Jun 30, 2026 |
| Fidelity SAI U.S. Quality Index Fund | 5,530,685 | 0.31% | $1.39B | 3.88% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert A. Michael | CHAIRMAN OF THE BOARD AND CEO, Director | 178,737 | 0.01% | Mar 3, 2026 |
| Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | 74,430 | 0.00% | Aug 18, 2026 |
| David Ryan Purdue | SVP, Controller | 9,011 | 0.00% | Mar 11, 2026 |
| Demetris D. Crum | EVP, CHIEF HR OFFICER | 7,914 | 0.00% | Mar 6, 2026 |
| Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | 84,509 | 0.00% | Mar 3, 2026 |
| Roopal Thakkar | EVP, R&D and CSO | 55,374 | 0.00% | Mar 3, 2026 |
| Azita Saleki-Gerhardt | EVP, CHIEF OPERATIONS OFFICER | 204,373 | 0.01% | Mar 3, 2026 |
| Perry C. Siatis | EVP, GC AND SECRETARY | 17,510 | 0.00% | Mar 3, 2026 |
| Scott T. Reents | EVP, CHIEF FINANCIAL OFFICER | 38,777 | 0.00% | Mar 3, 2026 |
| Inc. AbbVie | EVP, Chief HR Officer | 7,048 | 0.00% | Jul 11, 2025 |
| Timothy J. Richmond | EVP, CHIEF HR OFFICER | 6,130 | 0.00% | Mar 4, 2025 |
| Kevin K. Buckbee | SVP, CONTROLLER | 7,797 | 0.00% | Mar 4, 2025 |
| Susan E. Quaggin | Director | 3,643 | 0.00% | Jul 2, 2026 |
| Edward J. Rapp | Director | 56,352 | 0.00% | Jul 2, 2026 |
| Melody B. Meyer | Director | 17,616 | 0.00% | May 12, 2026 |
| Frederick H. Waddell | Director | 30,076 | 0.00% | May 12, 2026 |
| Jennifer L. Davis | Director | 3,643 | 0.00% | May 12, 2026 |
| Thomas J. Falk | Director | 5,321 | 0.00% | May 12, 2026 |
| Brett J. Hart | Director | 20,590 | 0.00% | May 12, 2026 |
| Rebecca B. Roberts | Director | 14,846 | 0.00% | May 12, 2026 |
| William H.L. Burnside | Director | 28,076 | 0.00% | May 12, 2026 |
| Thomas C. Freyman | Director | 133,810 | 0.01% | May 12, 2026 |
| Roxanne S. Austin | Director | 39,576 | 0.00% | May 12, 2026 |
| Robert J. Alpern | Director | 35,646 | 0.00% | Apr 2, 2026 |
| Glenn F. Tilton | Director | 51,914 | 0.00% | May 13, 2025 |
| Richard A. Gonzalez | Director | 415,894 | 0.02% | Apr 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Aug 14, 2026 | Sale | −32,710 | $250.00 | $8.18M | 74,430 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Aug 14, 2026 | Option exercise | +32,710 | $79.02 | $2.58M | 107,140 |
| William H.L. Burnside Director | May 8, 2026 | Award | +1,118 | – | – | 28,076 |
| Jennifer L. Davis Director | May 8, 2026 | Award | +1,118 | – | – | 3,643 |
| Brett J. Hart Director | May 8, 2026 | Award | +1,118 | – | – | 20,590 |
| Roxanne S. Austin Director | May 8, 2026 | Award | +1,118 | – | – | 39,576 |
| Melody B. Meyer Director | May 8, 2026 | Award | +1,118 | – | – | 17,616 |
| Frederick H. Waddell Director | May 8, 2026 | Award | +1,118 | – | – | 30,076 |
| Rebecca B. Roberts Director | May 8, 2026 | Award | +1,118 | – | – | 14,846 |
| Thomas J. Falk Director | May 8, 2026 | Award | +1,118 | – | – | 2,321 |
| Thomas C. Freyman Director | May 8, 2026 | Award | +1,118 | – | – | 127,869 |
| Susan E. Quaggin Director | May 8, 2026 | Award | +1,118 | – | – | 3,643 |
| Edward J. Rapp Director | May 8, 2026 | Award | +1,118 | – | – | 45,964 |
| David Ryan Purdue SVP, Controller | Mar 4, 2026 | Sale | −5,230 | $233.56 | $1.22M | 2,654 |
| Perry C. Siatis EVP, GC AND SECRETARY | Mar 2, 2026 | Sale(10b5-1 plan) | −5,777 | $233.51 | $1.35M | 17,510 |
| Perry C. Siatis EVP, GC AND SECRETARY | Mar 2, 2026 | Sale(10b5-1 plan) | −2,600 | $235.26 | $611.68K | 4,619 |
| Perry C. Siatis EVP, GC AND SECRETARY | Mar 2, 2026 | Sale(10b5-1 plan) | −10,291 | $234.66 | $2.41M | 7,219 |
| David Ryan Purdue SVP, Controller | Feb 27, 2026 | Tax withholding | −2,108 | $232.08 | $489.22K | 8,468 |
| Demetris D. Crum EVP, CHIEF HR OFFICER | Feb 27, 2026 | Tax withholding | −1,594 | $232.08 | $369.94K | 7,914 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Feb 27, 2026 | Tax withholding | −12,874 | $232.08 | $2.99M | 74,430 |
| Roopal Thakkar EVP, R&D and CSO | Feb 27, 2026 | Tax withholding | −8,037 | $232.08 | $1.87M | 52,376 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 27, 2026 | Tax withholding | −14,850 | $232.08 | $3.45M | 23,287 |
| Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | Feb 27, 2026 | Tax withholding | −23,812 | $232.08 | $5.53M | 83,171 |
| Scott T. Reents EVP, CHIEF FINANCIAL OFFICER | Feb 27, 2026 | Tax withholding | −21,638 | $232.08 | $5.02M | 38,777 |
| Robert A. Michael CHAIRMAN OF THE BOARD AND CEO, Director | Feb 27, 2026 | Tax withholding | −36,523 | $232.08 | $8.48M | 178,737 |
| David Ryan Purdue SVP, Controller | Feb 27, 2026 | Tax withholding | −2,692 | $232.08 | $624.76K | 7,884 |
| Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | Feb 27, 2026 | Tax withholding | −16,309 | $232.08 | $3.78M | 197,794 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 25, 2026 | Sale(10b5-1 plan) | −22,381 | $230.00 | $5.15M | 38,137 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 25, 2026 | Option exercise | +7,775 | $175.28 | $1.36M | 53,226 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 25, 2026 | Option exercise | +7,314 | $149.62 | $1.09M | 45,451 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 25, 2026 | Option exercise | +7,292 | $192.86 | $1.41M | 60,518 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 18, 2026 | Award | +5,792 | – | – | 26,701 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 18, 2026 | Award | +5,628 | – | – | 32,329 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 18, 2026 | Award | +16,290 | – | – | 20,909 |
| Perry C. Siatis EVP, GC AND SECRETARY | Feb 18, 2026 | Award | +5,808 | – | – | 38,137 |
| Demetris D. Crum EVP, CHIEF HR OFFICER | Feb 18, 2026 | Award | +1,216 | – | – | 8,264 |
| Demetris D. Crum EVP, CHIEF HR OFFICER | Feb 18, 2026 | Award | +1,244 | – | – | 9,508 |
| David Ryan Purdue SVP, Controller | Feb 18, 2026 | Award | +890 | – | – | 7,900 |
| David Ryan Purdue SVP, Controller | Feb 18, 2026 | Award | +2,505 | – | – | 7,010 |
| David Ryan Purdue SVP, Controller | Feb 18, 2026 | Award | +1,384 | – | – | 10,576 |
| David Ryan Purdue SVP, Controller | Feb 18, 2026 | Award | +1,292 | – | – | 9,192 |
| Robert A. Michael CHIEF EXECUTIVE OFFICER, Director | Feb 18, 2026 | Award | +22,124 | – | – | 215,260 |
| Robert A. Michael CHIEF EXECUTIVE OFFICER, Director | Feb 18, 2026 | Award | +33,833 | – | – | 166,654 |
| Robert A. Michael CHIEF EXECUTIVE OFFICER, Director | Feb 18, 2026 | Award | +12,030 | – | – | 178,684 |
| Robert A. Michael CHIEF EXECUTIVE OFFICER, Director | Feb 18, 2026 | Award | +14,452 | – | – | 193,136 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Feb 18, 2026 | Award | +5,172 | – | – | 81,082 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Feb 18, 2026 | Award | +4,632 | – | – | 75,910 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Feb 18, 2026 | Award | +6,222 | – | – | 87,304 |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | Feb 18, 2026 | Award | +13,031 | – | – | 71,278 |
| Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | Feb 18, 2026 | Award | +26,063 | – | – | 79,297 |
| Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | Feb 18, 2026 | Award | +8,988 | – | – | 106,983 |
| Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | Feb 18, 2026 | Award | +9,432 | – | – | 97,995 |
| Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | Feb 18, 2026 | Award | +9,266 | – | – | 88,563 |
| Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | Feb 18, 2026 | Award | +6,638 | – | – | 214,103 |
| Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | Feb 18, 2026 | Award | +7,074 | – | – | 207,465 |
| Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | Feb 18, 2026 | Award | +17,041 | – | – | 194,333 |
| Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | Feb 18, 2026 | Award | +6,058 | – | – | 200,391 |
| Roopal Thakkar EVP, R&D and CSO | Feb 18, 2026 | Award | +2,138 | – | – | 50,429 |
| Roopal Thakkar EVP, R&D and CSO | Feb 18, 2026 | Award | +3,346 | – | – | 53,775 |
| Roopal Thakkar EVP, R&D and CSO | Feb 18, 2026 | Award | +6,638 | – | – | 60,413 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Donoghoe Nicholas Officer | Aug 14, 2026 | 32,710 | $8.18M | Aug 14, 2026 | Stock Option Exercise |
| J. Alpern Robert Director | May 26, 2026 | 13,000 | $2.78M | May 26, 2026 | Restricted Stock |
| R. Purdue David Officer | Mar 6, 2026 | 5,230 | $1.22M | Mar 4, 2026 | Restricted Stock |
| C. Siatis Perry Officer | Mar 2, 2026 | 18,668 | $4.38M | Mar 2, 2026 | Performance Shares |
| C. Siatis Perry Officer | Feb 25, 2026 | 22,381 | $5.15M | Feb 25, 2026 | Stock Option Exercise |
| A. Gonzalez Richard Former Director | Aug 22, 2025 | 62,755 | $13.23M | Aug 22, 2025 | Stock Option Exercise |
| A. Gonzalez Richard Former Director | Aug 21, 2025 | 90,000 | $18.99M | Aug 21, 2025 | Stock Option Exercise |
| Saleki-Gerhardt Azita Officer | Aug 12, 2025 | 42,370 | $8.41M | Aug 12, 2025 | Stock Option Exercise |
| A. Gonzalez Richard Former Director | Aug 8, 2025 | 188,220 | $38.08M | Aug 1, 2025 | Restricted Stock |
| Donoghoe Nicholas Officer | Aug 5, 2025 | 13,299 | $2.64M | Aug 5, 2025 | Dividend Reinvestment Shares |
| Jeffrey Ryan Stewart Officer | Mar 31, 2025 | 58,832 | $12.36M | Mar 31, 2025 | RESTRICTED STOCK |
| Scott T. Reents Officer | Mar 14, 2025 | 17,644 | $3.75M | Mar 14, 2025 | RESTRICTED STOCK |
| Richard A. Gonzalez Officer | Mar 3, 2025 | 6,168 | $1.30M | Mar 3, 2025 | PERFORMANCE SHARES |
| C. Siatis Perry Officer | Mar 3, 2025 | 18,008 | $3.78M | Mar 3, 2025 | Stock Option Exercise |
| Richmond Timothy Officer | Mar 3, 2025 | 21,250 | $4.47M | Mar 3, 2025 | Performance Shares |